收藏切换
Effect of renvastinib on the level of AFP-L3, AFP, DCP and immune function in patients with hepatocellular carcinoma after radiofrequency ablation
收藏切换
Dandan DONG1, Li QIU1, Yi HU1, Jianzhong LIU2, *
World Clinical Drug | 2025, 46(3) : 254 - 259
Less
收藏切换
World Clinical Drug | 2025, 46(3): 254-259
• Article •
Effect of renvastinib on the level of AFP-L3, AFP, DCP and immune function in patients with hepatocellular carcinoma after radiofrequency ablation
Full
Dandan DONG1, Li QIU1, Yi HU1, Jianzhong LIU2, *
Affiliations
  • 1.Department of Infectious Liver Disease, Wuhan NO.7 Hospital, Wuhan 430071, Hubei Province, China
  • 2.Inspection Center, Wuhan NO.7 Hospital, Wuhan 430071, Hubei Province, China
Published: 2025-03-10 doi: 10.13683/j.wph.2025.03.008
Outline
收藏切换
Objective

To investigate the efficacy of lenvatinib in treating liver cancer patients after radiofrequency ablation(RFA) and its effects on serum alpha-fetoprotein variant(AFP)-L3, AFP, abnormal prothrombin(DCP) levels and immune function.

Methods

A total of 209 patients with liver cancer admitted to our hospital from August 2021 to August 2024 were selected and divided into control group(n=105) and experimental group(n=104). After RFA treatment, the control group was treated with FOLFOX regimen, and the experimental group was treated with lenvatinib. Clinical efficacy, serum AFP-L3, AFP and DCP levels, immune function and the changes of aspartate aminotransferase(AST), alanine aminotransferase(ALT), total bilirubin(TBil) levels and complications were observed in the two groups.

Results

After treatment, the clinical effect of experimental group was higher than that of control group(85.71% vs. 69.23%)(P<0.05). Serum levels of AFP-L3, AFP and DCP in both groups were decreased compared with those before treatment, and the experimental group was lower than the control group (P<0.05). The levels of cluster of differentiation(CD)3+, CD4+ and CD4+/CD8+ in both groups were increased compared with before treatment, and the experimental group was higher than the control group (P<0.05). The levels of CD8+, AST, ALT and TBil in both groups were all decreased than before treatment, and the experimental group was lower than the control group(P<0.05). There was no significant difference in the total incidence of complications between the two groups(P>0.05).

Conclusion

Lenvatinib combined with RFA can improve the level of AFP-L3, AFP, DCP and immune function, and improve the control effect of tumor in patients with liver cancer.

renvastinib  /  radio frequency ablation  /  liver cancer  /  alpha-fetoprotein variant  /  abnormal prothrombin  /  immune function
董丹丹, 邱利, 胡毅, 刘建中. 仑伐替尼对行射频消融术后肝癌患者疗效及对AFP-L3、AFP、DCP水平及免疫功能的影响. 世界临床药物, 2025 , 46 (3) : 254 -259 . DOI: 10.13683/j.wph.2025.03.008
Dandan DONG, Li QIU, Yi HU, Jianzhong LIU. Effect of renvastinib on the level of AFP-L3, AFP, DCP and immune function in patients with hepatocellular carcinoma after radiofrequency ablation[J]. World Clinical Drug, 2025 , 46 (3) : 254 -259 . DOI: 10.13683/j.wph.2025.03.008
Year 2025 volume 46 Issue 3
46
10
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.03.008
  • Receive Date:2025-01-28
  • Online Date:2026-11-10
  • Published:2025-03-10
Article Data
Affiliations
History
  • Received:2025-01-28
Affiliations
    1.Department of Infectious Liver Disease, Wuhan NO.7 Hospital, Wuhan 430071, Hubei Province, China
    2.Inspection Center, Wuhan NO.7 Hospital, Wuhan 430071, Hubei Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.03.008
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT